Methods and compositions for direct chemical lysis

US10190152B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10190152-B2
Application numberUS-87460210-A
CountryUS
Kind codeB2
Filing dateSep 2, 2010
Priority dateSep 3, 2009
Publication dateJan 29, 2019
Grant dateJan 29, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A direct chemical lysis composition includes an assay compatible buffer composition and an assay compatible surfactant. When combined with a specimen storage composition, such compositions prevent undesired modifications to nucleic acid and proteins lysed from cells in the biological sample. Assays of samples from such compositions do not require expensive and time-consuming steps such as centrifugation and prolonged high temperature processing. The direct chemical lysis composition of the present invention permits direct nucleic acid extraction from the cells in the biological sample without the need to decant off the transport media or otherwise exchange the transport media with assay compatible buffers. There is no need to combine the sample with proteinase K or another enzyme to extract nucleic acids from the cells. A method for lysing cells to obtain target nucleic acid for assay and a kit for combining the direct chemical lysis composition with a sample are also contemplated.

First claim

Opening claim text (preview).

What is claimed is: 1. A composition consisting of a direct chemical lysis composition in combination with a liquid-based cytology sample or a formalin-fixed, paraffin embedded sample, the direct chemical lysis composition consisting of: a) a buffer composition comprising a buffer component and a metal salt component, wherein the metal salt component is selected from the group consisting of sodium chloride (NaCl), potassium chloride (KCl), sodium acetate (C 2 H 3 NaO 2 ) and ammonium sulfate ((NH 4 ) 2 SO 4 ), wherein a concentration of the buffer component is in a range of 0.2 M to 2 M and a concentration of the metal salt component is in a range of 0.01 M to 1 M; and b) a non-ionic surfactant wherein a concentration of the non-ionic surfactant is in a range of 0.01 to 2 percent (v/v). 2. The direct chemical lysis composition of claim 1 wherein the direct chemical lysis composition has a pH of about 6.6 to about 10. 3. The direct chemical lysis composition of claim 1 wherein the metal salt component is NaCl and the NaCl concentration is in the range of 0.01 M to 1 M. 4. The direct chemical lysis composition of claim 3 wherein the buffer component is selected from the group consisting of tris(hydroxymethyl)amino methane and an acid salt of tris(hydroxymethyl)amino methane. 5. The direct chemical lysis composition of claim 4 wherein the non-ionic surfactant is a polyethylene glycol based non-ionic surfactant. 6. The direct chemical lysis composition of claim 1 wherein the non-ionic surfactant is selected from the group consisting of polyoxyethylene (20) sorbitol monolaurate and polyethylene glycol octyphenyl ether. 7. The direct chemical lysis composition of claim 6 wherein the buffer component is an acid salt of tris(hydroxymethyl)amino methane and the buffer component concentration is 0.75 M, the metal salt component is NaCl and the NaCl concentration is 0.19 M and the non-ionic surfactant is polyethylene glycol octylphenyl ether and the polyethylene glycol octylphenyl ether concentration is about 0.75 percent (v/v).

Assignees

Inventors

Classifications

  • C12Q1/6806Primary

    Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

  • Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus · CPC title

  • for papilloma · CPC title

  • Viruses · CPC title

  • Lysis of microorganisms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10190152B2 cover?
A direct chemical lysis composition includes an assay compatible buffer composition and an assay compatible surfactant. When combined with a specimen storage composition, such compositions prevent undesired modifications to nucleic acid and proteins lysed from cells in the biological sample. Assays of samples from such compositions do not require expensive and time-consuming steps such as centr…
Who is the assignee on this patent?
Yang Feng, Wang Sha Sha, Vaughan Laurence Michael, and 3 more
What technology area does this patent fall under?
Primary CPC classification C12Q1/6806. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).